Mazyar Shadman, MD, MPH, Reports the Latest BTKi News in CLL

By Chadi Nabhan, MD, MBA, FACP - Last Updated: August 24, 2023

In this episode of The HemOnc Pulse, Dr. Shadman of the Fred Hutchinson Cancer Center in Seattle joins host Chadi Nabhan, MD, MBA, FACP, to round up the latest news in chronic lymphocytic leukemia (CLL) from the summer conferences, including updates on novel Bruton’s tyrosine kinase inhibitor (BTKi) therapies in CLL.

Advertisement

Dr. Shadman also discusses data from the ALPINE, BRUIN, and MAJIC trials and highlights what he sees on the horizon for CLL treatment and research.

Find all episodes of The HemOnc Pulse here.

Advertisement
Advertisement
Advertisement
Editorial Board